NAMS

NEWAMSTERDAM PHARMA COMPANY

Institutional Ownership · Q4 2025

Filing: Q4 2025

NEWAMSTERDAM PHARMA COMPANY (NAMS) is held by 179 institutional investors with combined holdings of $4.1B. Major holders include Frazier Life Sciences Man, Capital World Investors, RA CAPITAL MANAGEMENT, L..

💰 Dark Pool Activity 👤 Insider Trades

Institutional Holders

179

Total Value

$4.1B

Ownership %

102.7%

🏦 Top Institutional Holders

Frazier Life Sciences Management, L.P.

17.4M shares

$605.9M

15.17% ownership

Capital World Investors

10.0M shares

$350.2M

8.68% ownership

RA CAPITAL MANAGEMENT, L.P.

9.9M shares

$342.7M

8.60% ownership

FCPM III SERVICES B.V.

9.2M shares

$322.7M

8.00% ownership

Bain Capital Life Sciences Investors, LLC

7.4M shares

$258.6M

6.44% ownership

📊 Financials

Income statement, balance sheet, and cash flow from SEC filings.

🏦 Browse Funds

See complete portfolios of top hedge funds.

🎯 AI Signals

Find stocks where multiple funds are accumulating.